Deborah Waterhouse was appointed to GSK’s Corporate Executive Team on January 8, 2020. She became Chief Executive Officer of ViiV Healthcare on April 1, 2017. Deborah joined GSK in 1996 and was most recently the Senior Vice President of Primary Care within the company’s US business, prior to which she led the US Vaccines business. She brings a wealth of experience to ViiV Healthcare, having lived and worked in Europe, Asia Pacific and the US, and a strong track record of performance in both specialty and primary care. Deborah led the HIV business in the UK before heading the HIV Centre of Excellence for Pharma Europe, and held international roles as General Manager of Australia and New Zealand and Senior Vice President for Central and Eastern Europe. www. ceotodaymagazine . com CEO Today Un i t ed Ki ngdom Awa rds 202 2 About Deborah Waterhouse I’m proud to lead ViiV Healthcare – a company on a mission to leave no person living with HIV behind. ViiV is a global specialist HIV company, 100% focused on researching and delivering new medicines and improving access to care for people living with HIV. 18
RkJQdWJsaXNoZXIy Mjk3Mzkz